Menu
US
neuroblastoma-molecular-1920x400.jpg
Application Note

Quantifying the degradation of RBM39 in Neuroblastoma cells treated with molecular glue degraders using HTRF technology

See the potential of molecular glue degraders

RNA-binding motif protein 39 is a key factor in tumor-targeted RNA and protein expression that plays an important role in tumorigenesis. It’s important to study the interaction between RBM39 and tumors.

Download this application note, which highlights the use of HTRF immunoassays to evaluate RBM39 degradation in neuroblastoma cancer cells treated with Indilsulam and CeMM1-4 molecular glue degraders.

For research use only. Not for use in diagnostic procedures.

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Download Resource

Quantifying the degradation of RBM39 in Neuroblastoma cells treated with molecular glue degraders using HTRF technology

Download Application Note